Autres langues Heart Test Laboratories, Inc.

Actions

HSCS

US42254E3027

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 25/06/2024			Varia. 5j.	Varia. 1 janv.
5,35 ^USD	-3,60%		+4,70%	-68,71%

24/04	HeartSciences annonce la délivrance par l'Office européen des brevets d'un brevet fondamental portant sur l'évaluation de la fonction diastolique du cœur à l'aide de l'AI-ECG	CI
26/03	HeartSciences annonce une présentation au Congrès mondial des anesthésiologistes sur l'utilité de l'ECG par ondelettes MyoVista® pour la détection de la dysfonction diastolique du ventricule gauche chez les patients en préopératoire	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

HeartSciences Regains Compliance with Nasdaq Listing Requirements	04/06
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio	20/05
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	24/04
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	24/04
HeartSciences to Present at the LD Micro Invitational XIV Conference	02/04
HeartSciences to Present at the LD Micro Invitational XIV Conference	02/04
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	26/03
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	26/03
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results	14/03
Heart Test Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	14/03
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes	12/03
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology	06/03
HeartSciences Adds Key Advisor to its Scientific Advisory Board	26/02
HeartSciences Adds Key Advisor to its Scientific Advisory Board	26/02
Heart Test Laboratories, Inc. Appoints Partho P. Sengupta to Its Scientific Advisory Board	26/02
HeartSciences Expands its Scientific Advisory Board	12/02
Heart Test Laboratories, Inc. Appoints Jordan B. Strom to Its Scientific Advisory Board	12/02
HeartSciences Appoints New Scientific Advisory Board Member	01/02
HeartSciences Appoints New Scientific Advisory Board Member	01/02
HeartSciences Appoints Benjamin Glicksberg to its Scientific Advisory Board	01/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Heart Test Laboratories, Inc.

Actions

HSCS

US42254E3027

Autres langues

Filtres